Closed‐Loop AI Systems for Arrhythmia Management: Toward Predictive, Personalized, and Safe Cardiac Care
Clinical Cardiology · 2026
DOI: 10.1002/clc.70468 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Mohammed AbuBaha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, An-Najah National University, Nablus, Palestine. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Artificial Intelligence, Precision Medicine. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiac arrhythmias impose a substantial global health and economic burden. Despite advances in electrophysiology and device‐based therapy, management still depends on episodic monitoring and delayed decision‐making, leaving a persistent gap between detection and intervention that is widest for intermittent and asymptomatic rhythm disturbances.
Objective
This narrative review traces the shift from open‐loop arrhythmia care to closed‐loop, AI‐assisted systems that couple continuous sensing, automated decision‐making, and therapeutic actuation within a feedback‐controlled architecture. Its contribution is to reframe arrhythmia AI around the control loop and its safety constraints rather than around detection accuracy alone, addressing a gap left by reviews that focus on classification algorithms or digital‐twin modeling.
Methods
We synthesized evidence from landmark device‐programming trials, foundational work in control theory and machine learning, and current regulatory guidance to define the principles, technological basis, and system‐level requirements of closed‐loop arrhythmia care. As a narrative review, it emphasizes control logic, safety constraints, feedback, and clinical integration rather than algorithmic performance in isolation.
Results
Device‐programming trials show that conservative timing, hierarchical escalation, and defined safety boundaries reduce inappropriate therapy and can improve survival, establishing the control principles on which AI systems must build. Machine learning extends these principles to scalable monitoring and adaptive decision‐making but introduces concerns of stability, transparency, bias, and performance drift. Safe implementation therefore requires dependable sensing, bounded adaptation, supervisory control, and lifecycle evaluation.
Conclusions
Closed‐loop AI extends established electrophysiologic control principles rather than replacing clinical judgment. Embedded within transparent, governed architectures with bounded adaptation and human oversight, such systems may improve the personalization, safety, and outcomes of arrhythmia care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, An-Najah National University, Nablus, Palestine.
- Department of Medicine, Al-Quds University, Jerusalem, Palestine.
ORCID-Profile: Mohammed AbuBaha, Yousef I Barqawi, Bara AbuBaha, Mohammed Saleh, Sarah Saife, Yahia AlJallad, Hossam Salameh
Zitieren
APA
AbuBaha, M., Barqawi, Y. I., AbuBaha, B., Bishawi, S., Hamada, D., Saleh, M., Saife, S., AlJallad, Y., Salah, E., Salah, A., & Salameh, H. (2026). Closed‐Loop AI Systems for Arrhythmia Management: Toward Predictive, Personalized, and Safe Cardiac Care. Clinical Cardiology. https://doi.org/10.1002/clc.70468
Vancouver
AbuBaha M, Barqawi YI, AbuBaha B, Bishawi S, Hamada D, Saleh M, et al. Closed‐Loop AI Systems for Arrhythmia Management: Toward Predictive, Personalized, and Safe Cardiac Care. Clinical Cardiology. 2026. doi:10.1002/clc.70468
BibTeX
@article{AbuBaha2026,
author = {AbuBaha, Mohammed and Barqawi, Yousef I and AbuBaha, Bara and Bishawi, Salsabeel and Hamada, Duma and Saleh, Mohammed and Saife, Sarah and AlJallad, Yahia and Salah, Elias and Salah, Anas and Salameh, Hossam},
title = {Closed‐Loop AI Systems for Arrhythmia Management: Toward Predictive, Personalized, and Safe Cardiac Care},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70468}
}
EUVIMED